BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 30665880)

  • 1. Immunomagnetic selective donor-derived CD4
    Varlet P; Rogeau S; Trauet J; Demaret J; Labalette M
    Curr Res Transl Med; 2019 Feb; 67(1):1-7. PubMed ID: 30665880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The impact of donor naive and memory T cell subsets on patient outcome following allogeneic stem cell transplantation: relationship between infused donor CD4+/CCR7+ T cell subsets and acute graft-versus-host disease].
    Choufi B; Thiant S; Trauet J; Cliquennois M; Cherrel M; Boulanger F; Coiteux V; Magro L; Labalette M; Yakoub-Agha I
    Pathol Biol (Paris); 2014 Jun; 62(3):123-8. PubMed ID: 24906571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative analysis of naïve and memory CD4+ and CD8+ T-cell subsets in bone marrow and G-CSF-mobilized peripheral blood stem cell allografts: impact of donor characteristics.
    Yakoub-Agha I; Saule P; Depil S; Grutzmacher C; Boulanger F; Magro L; Jouet JP; Dessaint JP; Labalette M
    Exp Hematol; 2007 Jun; 35(6):861-71. PubMed ID: 17533040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Donor-derived CD4(+)/CCR7(+) T-cell partial selective depletion does not alter acquired anti-infective immunity.
    Choufi B; Trauet J; Thiant S; Labalette M; Yakoub-Agha I
    Bone Marrow Transplant; 2014 May; 49(5):611-5. PubMed ID: 24566708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of alloreactivity-reduced donor lymphocyte products retaining memory function by fully automatic depletion of CD45RA-positive cells.
    Müller N; Landwehr K; Langeveld K; Stenzel J; Pouwels W; van der Hoorn MAWG; Seifried E; Bonig H
    Cytotherapy; 2018 Apr; 20(4):532-542. PubMed ID: 29500069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A high proportion of donor CD4+ T cells expressing the lymph node-homing chemokine receptor CCR7 increases incidence and severity of acute graft-versus-host disease in patients undergoing allogeneic stem cell transplantation for hematological malignancy.
    Yakoub-Agha I; Saule P; Depil S; Micol JB; Grutzmacher C; Boulanger-Villard F; Bauters F; Jouet JP; Dessaint JP; Labalette M
    Leukemia; 2006 Sep; 20(9):1557-65. PubMed ID: 16826221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective depletion of alloreactive donor lymphocytes: a novel method to reduce the severity of graft-versus-host disease in older patients undergoing matched sibling donor stem cell transplantation.
    Solomon SR; Mielke S; Savani BN; Montero A; Wisch L; Childs R; Hensel N; Schindler J; Ghetie V; Leitman SF; Mai T; Carter CS; Kurlander R; Read EJ; Vitetta ES; Barrett AJ
    Blood; 2005 Aug; 106(3):1123-9. PubMed ID: 15817673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I study of high-stringency CD8 depletion of donor leukocyte infusions after allogeneic hematopoietic stem cell transplantation.
    Orti G; Lowdell M; Fielding A; Samuel E; Pang K; Kottaridis P; Morris E; Thomson K; Peggs K; Mackinnon S; Chakraverty R
    Transplantation; 2009 Dec; 88(11):1312-8. PubMed ID: 19996931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Donor-derived CD4
    Varlet P; Alsuliman T; Trauet J; Demaret J; Labalette M; Yakoub-Agha I
    Bone Marrow Transplant; 2019 Oct; 54(10):1686-1693. PubMed ID: 30890769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunologic recovery in children after alternative donor allogeneic transplantation for hematologic malignancies: comparison of recipients of partially T cell-depleted peripheral blood stem cells and umbilical cord blood.
    Oshrine BR; Li Y; Teachey DT; Heimall J; Barrett DM; Bunin N
    Biol Blood Marrow Transplant; 2013 Nov; 19(11):1581-9. PubMed ID: 23939199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineering human peripheral blood stem cell grafts that are depleted of naïve T cells and retain functional pathogen-specific memory T cells.
    Bleakley M; Heimfeld S; Jones LA; Turtle C; Krause D; Riddell SR; Shlomchik W
    Biol Blood Marrow Transplant; 2014 May; 20(5):705-16. PubMed ID: 24525279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alloreactive and leukemia-reactive T cells are preferentially derived from naive precursors in healthy donors: implications for immunotherapy with memory T cells.
    Distler E; Bloetz A; Albrecht J; Asdufan S; Hohberger A; Frey M; Schnürer E; Thomas S; Theobald M; Hartwig UF; Herr W
    Haematologica; 2011 Jul; 96(7):1024-32. PubMed ID: 21486863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naïve subset develops the most important alloreactive response among human CD4+ T lymphocytes in human leukocyte antigen-identical related setting.
    Chérel M; Choufi B; Trauet J; Cracco P; Dessaint JP; Yakoub-Agha I; Labalette M
    Eur J Haematol; 2014 Jun; 92(6):491-6. PubMed ID: 24520815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD34 positive selection as prophylaxis against graft versus host disease in allogeneic peripheral blood stem cell transplantation.
    Butt NM; McGinnity N; Clark RE
    Leuk Lymphoma; 2003 Sep; 44(9):1509-13. PubMed ID: 14565652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective Depletion of αβ T Cells and B Cells for Human Leukocyte Antigen-Haploidentical Hematopoietic Stem Cell Transplantation. A Three-Year Follow-Up of Procedure Efficiency.
    Li Pira G; Malaspina D; Girolami E; Biagini S; Cicchetti E; Conflitti G; Broglia M; Ceccarelli S; Lazzaro S; Pagliara D; Meschini A; Bertaina A; Montanari M; Locatelli F
    Biol Blood Marrow Transplant; 2016 Nov; 22(11):2056-2064. PubMed ID: 27519279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haploidentical hematopoietic stem cell transplantation in hematologic malignancies with G-CSF mobilized bone marrow plus peripheral blood stem cells grafts without T cell depletion: a single center report of 29 cases.
    Wang HX; Yan HM; Wang ZD; Xue M; Liu J; Guo ZK
    Leuk Lymphoma; 2012 Apr; 53(4):654-9. PubMed ID: 21929286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD8+ cell depletion of donor lymphocyte infusions using cd8 monoclonal antibody-coated high-density microparticles (CD8-HDM) after allogeneic hematopoietic stem cell transplantation: a pilot study.
    Alyea EP; Canning C; Neuberg D; Daley H; Houde H; Giralt S; Champlin R; Atkinson K; Soiffer RJ
    Bone Marrow Transplant; 2004 Jul; 34(2):123-8. PubMed ID: 15133487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allogeneic transplantation of selected CD34+ cells from peripheral blood: experience of 62 cases using immunoadsorption or immunomagnetic technique. Spanish Group of Allo-PBT.
    Urbano-Ispizua A; Solano C; Brunet S; de la Rubia J; Odriozola J; Zuazu J; Figuera A; Caballero D; Martínez C; García J; Sanz G; Torrabadella M; Alegre A; Pérez-Oteiza J; Jurado M; Oyonarte S; Sierra J; García-Conde J; Rozman C
    Bone Marrow Transplant; 1998 Sep; 22(6):519-25. PubMed ID: 9758337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depletion of naive T cells using clinical grade magnetic CD45RA beads: a new approach for GVHD prophylaxis.
    Teschner D; Distler E; Wehler D; Frey M; Marandiuc D; Langeveld K; Theobald M; Thomas S; Herr W
    Bone Marrow Transplant; 2014 Jan; 49(1):138-44. PubMed ID: 23933765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.